PPAR Research: Vol 2008, No 1

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

PPAR Research

Journal list menu

Tools

Follow journal

PPARs: A Double-Edged Sword in Cancer Therapy?

Peroxisome Proliferator-Activated Receptor δ: A Target with a Broad Therapeutic Potential for Drug Discovery

Development of Synthetic Modulators of PPARs: Current Challenges and Future Opportunities

PPARγ in Kidney Physiology and Pathophysiology

Combination Therapy of PPARγ Ligands and Inhibitors of Arachidonic Acid in Lung Cancer

Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy

Protective Actions of PPAR-γ Activation in Renal Endothelium

The Role of NF-κB in PPARα-Mediated Hepatocarcinogenesis

Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARα + γ Agonists

The Role of PPARγ Receptors and Leukotriene B4 Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer

PPAR-δ in Vascular Pathophysiology

Statins Activate Human PPARα Promoter and Increase PPARα mRNA Expression and Activation in HepG2 Cells

PPARs Mediate Lipid Signaling in Inflammation and Cancer

Clinical Use of PPARγ Ligands in Cancer

Regulation of Peroxisome Proliferator-Activated Receptors by E6-Associated Protein

Antidiabetic Rosiglitazone Reduces Soluble Intercellular Adhesion Molecule-1 Level in Type 2 Diabetic Patients with Coronary Artery Disease

The Potential Applications of Peroxisome Proliferator-Activated Receptor δ Ligands in Assisted Reproductive Technology

PPARγ, PTEN, and the Fight against Cancer

Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated Receptors

The Role of PPARs in the Endothelium: Implications for Cancer Therapy

PPARγ and Agonists against Cancer: Rational Design of Complementation Treatments

Peroxisome Proliferator-Activated Receptor β/δ in the Brain: Facts and Hypothesis

PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells

Potential Therapeutic Use of PPARγ-Programed Human Monocyte-Derived Dendritic Cells in Cancer Vaccination Therapy

PPARδ Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities

The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer

Peroxisome Proliferator-Activated Receptor Delta: A Conserved Director of Lipid Homeostasis through Regulation of the Oxidative Capacity of Muscle

Regulation of Cell Proliferation and Differentiation by PPARβ/δ

[Retracted] Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms

Retraction(s) for this article

Retracted: Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms

Retracted: Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms

PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion

Cross-Species Differential Plasma Protein Binding of MBX-102/JNJ39659100: A Novel PPAR-γ Agonist

To Live or to Die: Prosurvival Activity of PPARγ in Cancers

TZDs and Bone: A Review of the Recent Clinical Evidence

Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention

PPARγ: The Portrait of a Target Ally to Cancer Chemopreventive Agents

CXCR4 in Cancer and Its Regulation by PPARγ

Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types

PPARα- and DEHP-Induced Cancers

The Role of PPARγ in the Cyclooxygenase Pathway in Lung Cancer

Omega-3 Fatty Acids and PPARγ in Cancer

The Development of INT131 as a Selective PPARγ Modulator: Approach to a Safer Insulin Sensitizer

Peroxisome Proliferator-Activated Receptors in the Modulation of the Immune/Inflammatory Response in Atherosclerosis

Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies

Activation of Penile Proadipogenic Peroxisome Proliferator-Activated Receptor γ with an Estrogen: Interaction with Estrogen Receptor Alpha during Postnatal Development

Chondrosarcoma and Peroxisome Proliferator-Activated Receptor

PPARα Ligands as Antitumorigenic and Antiangiogenic Agents

Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors

Activated PPARγ Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells

PPARs in Neuroinflammation

Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling

Role of Peroxisome Proliferator-Activated Receptor Alpha in the Control of Cyclooxygenase 2 and Vascular Endothelial Growth Factor: Involvement in Tumor Growth

PPAR Regulation of Inflammatory Signaling in CNS Diseases

PPARγ and Proline Oxidase in Cancer

PPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

PPARs in Alzheimer′s Disease

PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis

Pathophysiological Roles of PPARγ in Gastrointestinal Epithelial Cells

The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products

Do PPARγ Ligands Suppress the Growth of Cholangiocarcinoma or the Cholangiohepatitis Induced by the Tumor?

A Novel Mechanism of PPARγ Regulation of TGFβ1: Implication in Cancer Biology

Macrophages, PPARs, and Cancer

The Role of PPAR-γ and Its Interaction with COX-2 in Pancreatic Cancer

The PPAR-γ Agonist 15-Deoxy-Δ12,14-Prostaglandin J2 Attenuates Microglial Production of IL-12 Family Cytokines: Potential Relevance to Alzheimer′s Disease

PPARγ and Apoptosis in Cancer

PPAR-γ: Therapeutic Potential for Multiple Sclerosis

PPARγ and MEK Interactions in Cancer

Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists

The Role of PPARs in Cancer

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders

Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile Template

[Retracted] A Role for PPAR γ in the Regulation of Cytokines in Immune Cells and Cancer

Retraction(s) for this article

The Role of PPARγ Receptors and Leukotriene B₄ Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer

The PPAR-γ Agonist 15-Deoxy-Δ^12,14-Prostaglandin J₂ Attenuates Microglial Production of IL-12 Family Cytokines: Potential Relevance to Alzheimer′s Disease

Prevention of Oxidative Stress-Induced Retinal Pigment Epithelial Cell Death by the PPARγ Agonists, 15-Deoxy-Delta 12, 14-Prostaglandin J₂